^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Gastroesophageal Junction Adenocarcinoma |
| Regimen: | DOF (5-fluorouracil + docetaxel + oxaliplatin) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Gastroesophageal Junction Adenocarcinoma: Principles of systemic therapy…Other recommended regimens…Docetaxel, cisplatin or oxaliplatin, and fluorouracil
